Insulin glargine-yfgn U100 pen 3ML

Ended Awarded

Contract number
SPE2DR26FT0HQ
Awardee
Awarding agency
Obligated
$1,144

Award facts

Contract value 100% obligated
$1,143.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $1,143.80 delivery order to Amerisourcebergen Drug Corp on July 14, 2026, for Insulin Glargine-Yfgn U100 pen 3mL pharmaceutical supply.

Place of performance is Conshohocken, PA. Ultimate completion date is July 15, 2026. The order is firm fixed-price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and holds a single-award indefinite delivery contract (SPE2DX) with the Defense Logistics Agency valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for worldwide military healthcare supply.

Quick answers

Who was awarded contract SPE2DR26FT0HQ?

SPE2DR26FT0HQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2026.

How much is contract SPE2DR26FT0HQ worth?

The government has obligated $1,144 on SPE2DR26FT0HQ.

Is contract SPE2DR26FT0HQ an order under another contract?

Yes. SPE2DR26FT0HQ is a delivery order under SPE2DR25D3021, an indefinite delivery contract.

Was contract SPE2DR26FT0HQ competed?

The extent of competition for SPE2DR26FT0HQ was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award